Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial
用户HcPGoYeSv6fs
4个月前
128
10
已关闭
DOI: 10.1016/S2213-8587(22)00188-7
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213858722001887
其他信息:
出版社: Elsevier BV
作者: Nobuya Inagaki; Masakazu Takeuchi; Tomonori Oura; Takeshi Imaoka; Yutaka Seino